Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review
- 1 October 2021
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 163, 55-67
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2013
- Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trialThe Lancet Oncology, 2012
- Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future managementFrontiers in Oncology, 2012
- Spinal radiosurgery - efficacy and safety after prior conventional radiotherapyRadiation Oncology, 2011
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind studyThe Lancet, 2011
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind StudyJournal of Clinical Oncology, 2010
- Lapatinib in Combination With Radiation Diminishes Tumor Regrowth in HER2+ and Basal-Like/EGFR+ Breast Tumor XenograftsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Embolization of Musculoskeletal Bone TumorsSeminars in Interventional Radiology, 2010
- Percutaneous radiofrequency ablation of painful osseous metastasesCancer, 2009
- Risk of complications from bone metastases in breast cancerEuropean Journal of Cancer, 2000